Global Mumps Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Mumps Vaccine market size was valued at US$ 398 million in 2024 and is forecast to a readjusted size of USD 493 million by 2031 with a CAGR of 3.1% during review period.
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Mumps Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mumps Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mumps Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mumps Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mumps Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mumps Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mumps Vaccine, with price, sales quantity, revenue, and global market share of Mumps Vaccine from 2020 to 2025.
Chapter 3, the Mumps Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mumps Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mumps Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mumps Vaccine.
Chapter 14 and 15, to describe Mumps Vaccine sales channel, distributors, customers, research findings and conclusion.
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Mumps Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mumps Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Mumps Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mumps Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mumps Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mumps Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Child
- Adult
- Hospitals Pharmacies
- Retail Pharmacies
- MedImmune
- Johnson & Johnson
- Merck & Co., Inc.
- Sanofi
- Serum Institute of India
- Bavarian Nordic
- Astellas Pharma India
- CSL Limited
- Emergent BioSolutions
- GlaxoSmithKline
- Panacea Biotec, Ltd.
- Biological E Limited
- Bharat Biotech Ltd.
- Novavax, Inc.
- Novartis
- Sinovac Biotech, Ltd.
- Incepta Vaccine Limited
- Valneva SE
- VBI Vaccines
- PT Bio Farma
- Sharp & Dohme Corp
- Bionity
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mumps Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mumps Vaccine, with price, sales quantity, revenue, and global market share of Mumps Vaccine from 2020 to 2025.
Chapter 3, the Mumps Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mumps Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Mumps Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mumps Vaccine.
Chapter 14 and 15, to describe Mumps Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mumps Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Child
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Mumps Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals Pharmacies
1.4.3 Retail Pharmacies
1.5 Global Mumps Vaccine Market Size & Forecast
1.5.1 Global Mumps Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Mumps Vaccine Sales Quantity (2020-2031)
1.5.3 Global Mumps Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 MedImmune
2.1.1 MedImmune Details
2.1.2 MedImmune Major Business
2.1.3 MedImmune Mumps Vaccine Product and Services
2.1.4 MedImmune Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 MedImmune Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Mumps Vaccine Product and Services
2.2.4 Johnson & Johnson Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Mumps Vaccine Product and Services
2.3.4 Merck & Co., Inc. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck & Co., Inc. Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Mumps Vaccine Product and Services
2.4.4 Sanofi Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sanofi Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Mumps Vaccine Product and Services
2.5.4 Serum Institute of India Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Mumps Vaccine Product and Services
2.6.4 Bavarian Nordic Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bavarian Nordic Recent Developments/Updates
2.7 Astellas Pharma India
2.7.1 Astellas Pharma India Details
2.7.2 Astellas Pharma India Major Business
2.7.3 Astellas Pharma India Mumps Vaccine Product and Services
2.7.4 Astellas Pharma India Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Astellas Pharma India Recent Developments/Updates
2.8 CSL Limited
2.8.1 CSL Limited Details
2.8.2 CSL Limited Major Business
2.8.3 CSL Limited Mumps Vaccine Product and Services
2.8.4 CSL Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 CSL Limited Recent Developments/Updates
2.9 Emergent BioSolutions
2.9.1 Emergent BioSolutions Details
2.9.2 Emergent BioSolutions Major Business
2.9.3 Emergent BioSolutions Mumps Vaccine Product and Services
2.9.4 Emergent BioSolutions Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Emergent BioSolutions Recent Developments/Updates
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Mumps Vaccine Product and Services
2.10.4 GlaxoSmithKline Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GlaxoSmithKline Recent Developments/Updates
2.11 Panacea Biotec, Ltd.
2.11.1 Panacea Biotec, Ltd. Details
2.11.2 Panacea Biotec, Ltd. Major Business
2.11.3 Panacea Biotec, Ltd. Mumps Vaccine Product and Services
2.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Panacea Biotec, Ltd. Recent Developments/Updates
2.12 Biological E Limited
2.12.1 Biological E Limited Details
2.12.2 Biological E Limited Major Business
2.12.3 Biological E Limited Mumps Vaccine Product and Services
2.12.4 Biological E Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biological E Limited Recent Developments/Updates
2.13 Bharat Biotech Ltd.
2.13.1 Bharat Biotech Ltd. Details
2.13.2 Bharat Biotech Ltd. Major Business
2.13.3 Bharat Biotech Ltd. Mumps Vaccine Product and Services
2.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Bharat Biotech Ltd. Recent Developments/Updates
2.14 Novavax, Inc.
2.14.1 Novavax, Inc. Details
2.14.2 Novavax, Inc. Major Business
2.14.3 Novavax, Inc. Mumps Vaccine Product and Services
2.14.4 Novavax, Inc. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Novavax, Inc. Recent Developments/Updates
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Mumps Vaccine Product and Services
2.15.4 Novartis Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Novartis Recent Developments/Updates
2.16 Sinovac Biotech, Ltd.
2.16.1 Sinovac Biotech, Ltd. Details
2.16.2 Sinovac Biotech, Ltd. Major Business
2.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
2.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Sinovac Biotech, Ltd. Recent Developments/Updates
2.17 Incepta Vaccine Limited
2.17.1 Incepta Vaccine Limited Details
2.17.2 Incepta Vaccine Limited Major Business
2.17.3 Incepta Vaccine Limited Mumps Vaccine Product and Services
2.17.4 Incepta Vaccine Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Incepta Vaccine Limited Recent Developments/Updates
2.18 Valneva SE
2.18.1 Valneva SE Details
2.18.2 Valneva SE Major Business
2.18.3 Valneva SE Mumps Vaccine Product and Services
2.18.4 Valneva SE Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Valneva SE Recent Developments/Updates
2.19 VBI Vaccines
2.19.1 VBI Vaccines Details
2.19.2 VBI Vaccines Major Business
2.19.3 VBI Vaccines Mumps Vaccine Product and Services
2.19.4 VBI Vaccines Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 VBI Vaccines Recent Developments/Updates
2.20 PT Bio Farma
2.20.1 PT Bio Farma Details
2.20.2 PT Bio Farma Major Business
2.20.3 PT Bio Farma Mumps Vaccine Product and Services
2.20.4 PT Bio Farma Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 PT Bio Farma Recent Developments/Updates
2.21 Sharp & Dohme Corp
2.21.1 Sharp & Dohme Corp Details
2.21.2 Sharp & Dohme Corp Major Business
2.21.3 Sharp & Dohme Corp Mumps Vaccine Product and Services
2.21.4 Sharp & Dohme Corp Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Sharp & Dohme Corp Recent Developments/Updates
2.22 Bionity
2.22.1 Bionity Details
2.22.2 Bionity Major Business
2.22.3 Bionity Mumps Vaccine Product and Services
2.22.4 Bionity Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Bionity Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MUMPS VACCINE BY MANUFACTURER
3.1 Global Mumps Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Mumps Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Mumps Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Mumps Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Mumps Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Mumps Vaccine Manufacturer Market Share in 2024
3.5 Mumps Vaccine Market: Overall Company Footprint Analysis
3.5.1 Mumps Vaccine Market: Region Footprint
3.5.2 Mumps Vaccine Market: Company Product Type Footprint
3.5.3 Mumps Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Mumps Vaccine Market Size by Region
4.1.1 Global Mumps Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Mumps Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Mumps Vaccine Average Price by Region (2020-2031)
4.2 North America Mumps Vaccine Consumption Value (2020-2031)
4.3 Europe Mumps Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Mumps Vaccine Consumption Value (2020-2031)
4.5 South America Mumps Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Mumps Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Mumps Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Mumps Vaccine Consumption Value by Type (2020-2031)
5.3 Global Mumps Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Mumps Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Mumps Vaccine Consumption Value by Application (2020-2031)
6.3 Global Mumps Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Mumps Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Mumps Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Mumps Vaccine Market Size by Country
7.3.1 North America Mumps Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Mumps Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Mumps Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Mumps Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Mumps Vaccine Market Size by Country
8.3.1 Europe Mumps Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Mumps Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mumps Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Mumps Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Mumps Vaccine Market Size by Region
9.3.1 Asia-Pacific Mumps Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Mumps Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Mumps Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Mumps Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Mumps Vaccine Market Size by Country
10.3.1 South America Mumps Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Mumps Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mumps Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Mumps Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Mumps Vaccine Market Size by Country
11.3.1 Middle East & Africa Mumps Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Mumps Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Mumps Vaccine Market Drivers
12.2 Mumps Vaccine Market Restraints
12.3 Mumps Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Mumps Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mumps Vaccine
13.3 Mumps Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mumps Vaccine Typical Distributors
14.3 Mumps Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Mumps Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Child
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Mumps Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals Pharmacies
1.4.3 Retail Pharmacies
1.5 Global Mumps Vaccine Market Size & Forecast
1.5.1 Global Mumps Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Mumps Vaccine Sales Quantity (2020-2031)
1.5.3 Global Mumps Vaccine Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 MedImmune
2.1.1 MedImmune Details
2.1.2 MedImmune Major Business
2.1.3 MedImmune Mumps Vaccine Product and Services
2.1.4 MedImmune Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 MedImmune Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Mumps Vaccine Product and Services
2.2.4 Johnson & Johnson Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Mumps Vaccine Product and Services
2.3.4 Merck & Co., Inc. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck & Co., Inc. Recent Developments/Updates
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Mumps Vaccine Product and Services
2.4.4 Sanofi Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sanofi Recent Developments/Updates
2.5 Serum Institute of India
2.5.1 Serum Institute of India Details
2.5.2 Serum Institute of India Major Business
2.5.3 Serum Institute of India Mumps Vaccine Product and Services
2.5.4 Serum Institute of India Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Serum Institute of India Recent Developments/Updates
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Mumps Vaccine Product and Services
2.6.4 Bavarian Nordic Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bavarian Nordic Recent Developments/Updates
2.7 Astellas Pharma India
2.7.1 Astellas Pharma India Details
2.7.2 Astellas Pharma India Major Business
2.7.3 Astellas Pharma India Mumps Vaccine Product and Services
2.7.4 Astellas Pharma India Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Astellas Pharma India Recent Developments/Updates
2.8 CSL Limited
2.8.1 CSL Limited Details
2.8.2 CSL Limited Major Business
2.8.3 CSL Limited Mumps Vaccine Product and Services
2.8.4 CSL Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 CSL Limited Recent Developments/Updates
2.9 Emergent BioSolutions
2.9.1 Emergent BioSolutions Details
2.9.2 Emergent BioSolutions Major Business
2.9.3 Emergent BioSolutions Mumps Vaccine Product and Services
2.9.4 Emergent BioSolutions Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Emergent BioSolutions Recent Developments/Updates
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Mumps Vaccine Product and Services
2.10.4 GlaxoSmithKline Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GlaxoSmithKline Recent Developments/Updates
2.11 Panacea Biotec, Ltd.
2.11.1 Panacea Biotec, Ltd. Details
2.11.2 Panacea Biotec, Ltd. Major Business
2.11.3 Panacea Biotec, Ltd. Mumps Vaccine Product and Services
2.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Panacea Biotec, Ltd. Recent Developments/Updates
2.12 Biological E Limited
2.12.1 Biological E Limited Details
2.12.2 Biological E Limited Major Business
2.12.3 Biological E Limited Mumps Vaccine Product and Services
2.12.4 Biological E Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Biological E Limited Recent Developments/Updates
2.13 Bharat Biotech Ltd.
2.13.1 Bharat Biotech Ltd. Details
2.13.2 Bharat Biotech Ltd. Major Business
2.13.3 Bharat Biotech Ltd. Mumps Vaccine Product and Services
2.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Bharat Biotech Ltd. Recent Developments/Updates
2.14 Novavax, Inc.
2.14.1 Novavax, Inc. Details
2.14.2 Novavax, Inc. Major Business
2.14.3 Novavax, Inc. Mumps Vaccine Product and Services
2.14.4 Novavax, Inc. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Novavax, Inc. Recent Developments/Updates
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Mumps Vaccine Product and Services
2.15.4 Novartis Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Novartis Recent Developments/Updates
2.16 Sinovac Biotech, Ltd.
2.16.1 Sinovac Biotech, Ltd. Details
2.16.2 Sinovac Biotech, Ltd. Major Business
2.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
2.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Sinovac Biotech, Ltd. Recent Developments/Updates
2.17 Incepta Vaccine Limited
2.17.1 Incepta Vaccine Limited Details
2.17.2 Incepta Vaccine Limited Major Business
2.17.3 Incepta Vaccine Limited Mumps Vaccine Product and Services
2.17.4 Incepta Vaccine Limited Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Incepta Vaccine Limited Recent Developments/Updates
2.18 Valneva SE
2.18.1 Valneva SE Details
2.18.2 Valneva SE Major Business
2.18.3 Valneva SE Mumps Vaccine Product and Services
2.18.4 Valneva SE Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Valneva SE Recent Developments/Updates
2.19 VBI Vaccines
2.19.1 VBI Vaccines Details
2.19.2 VBI Vaccines Major Business
2.19.3 VBI Vaccines Mumps Vaccine Product and Services
2.19.4 VBI Vaccines Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 VBI Vaccines Recent Developments/Updates
2.20 PT Bio Farma
2.20.1 PT Bio Farma Details
2.20.2 PT Bio Farma Major Business
2.20.3 PT Bio Farma Mumps Vaccine Product and Services
2.20.4 PT Bio Farma Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 PT Bio Farma Recent Developments/Updates
2.21 Sharp & Dohme Corp
2.21.1 Sharp & Dohme Corp Details
2.21.2 Sharp & Dohme Corp Major Business
2.21.3 Sharp & Dohme Corp Mumps Vaccine Product and Services
2.21.4 Sharp & Dohme Corp Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Sharp & Dohme Corp Recent Developments/Updates
2.22 Bionity
2.22.1 Bionity Details
2.22.2 Bionity Major Business
2.22.3 Bionity Mumps Vaccine Product and Services
2.22.4 Bionity Mumps Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Bionity Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MUMPS VACCINE BY MANUFACTURER
3.1 Global Mumps Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Mumps Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Mumps Vaccine Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Mumps Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Mumps Vaccine Manufacturer Market Share in 2024
3.4.3 Top 6 Mumps Vaccine Manufacturer Market Share in 2024
3.5 Mumps Vaccine Market: Overall Company Footprint Analysis
3.5.1 Mumps Vaccine Market: Region Footprint
3.5.2 Mumps Vaccine Market: Company Product Type Footprint
3.5.3 Mumps Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Mumps Vaccine Market Size by Region
4.1.1 Global Mumps Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Mumps Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Mumps Vaccine Average Price by Region (2020-2031)
4.2 North America Mumps Vaccine Consumption Value (2020-2031)
4.3 Europe Mumps Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Mumps Vaccine Consumption Value (2020-2031)
4.5 South America Mumps Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Mumps Vaccine Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Mumps Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Mumps Vaccine Consumption Value by Type (2020-2031)
5.3 Global Mumps Vaccine Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Mumps Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Mumps Vaccine Consumption Value by Application (2020-2031)
6.3 Global Mumps Vaccine Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Mumps Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Mumps Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Mumps Vaccine Market Size by Country
7.3.1 North America Mumps Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Mumps Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Mumps Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Mumps Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Mumps Vaccine Market Size by Country
8.3.1 Europe Mumps Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Mumps Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mumps Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Mumps Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Mumps Vaccine Market Size by Region
9.3.1 Asia-Pacific Mumps Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Mumps Vaccine Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Mumps Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Mumps Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Mumps Vaccine Market Size by Country
10.3.1 South America Mumps Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Mumps Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mumps Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Mumps Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Mumps Vaccine Market Size by Country
11.3.1 Middle East & Africa Mumps Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Mumps Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Mumps Vaccine Market Drivers
12.2 Mumps Vaccine Market Restraints
12.3 Mumps Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Mumps Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Mumps Vaccine
13.3 Mumps Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Mumps Vaccine Typical Distributors
14.3 Mumps Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Mumps Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Mumps Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. MedImmune Basic Information, Manufacturing Base and Competitors
Table 4. MedImmune Major Business
Table 5. MedImmune Mumps Vaccine Product and Services
Table 6. MedImmune Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. MedImmune Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Mumps Vaccine Product and Services
Table 11. Johnson & Johnson Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co., Inc. Major Business
Table 15. Merck & Co., Inc. Mumps Vaccine Product and Services
Table 16. Merck & Co., Inc. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck & Co., Inc. Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Mumps Vaccine Product and Services
Table 21. Sanofi Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sanofi Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Mumps Vaccine Product and Services
Table 26. Serum Institute of India Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 29. Bavarian Nordic Major Business
Table 30. Bavarian Nordic Mumps Vaccine Product and Services
Table 31. Bavarian Nordic Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Bavarian Nordic Recent Developments/Updates
Table 33. Astellas Pharma India Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma India Major Business
Table 35. Astellas Pharma India Mumps Vaccine Product and Services
Table 36. Astellas Pharma India Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Astellas Pharma India Recent Developments/Updates
Table 38. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 39. CSL Limited Major Business
Table 40. CSL Limited Mumps Vaccine Product and Services
Table 41. CSL Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. CSL Limited Recent Developments/Updates
Table 43. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 44. Emergent BioSolutions Major Business
Table 45. Emergent BioSolutions Mumps Vaccine Product and Services
Table 46. Emergent BioSolutions Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Emergent BioSolutions Recent Developments/Updates
Table 48. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 49. GlaxoSmithKline Major Business
Table 50. GlaxoSmithKline Mumps Vaccine Product and Services
Table 51. GlaxoSmithKline Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Panacea Biotec, Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Panacea Biotec, Ltd. Major Business
Table 55. Panacea Biotec, Ltd. Mumps Vaccine Product and Services
Table 56. Panacea Biotec, Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Panacea Biotec, Ltd. Recent Developments/Updates
Table 58. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 59. Biological E Limited Major Business
Table 60. Biological E Limited Mumps Vaccine Product and Services
Table 61. Biological E Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Biological E Limited Recent Developments/Updates
Table 63. Bharat Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Bharat Biotech Ltd. Major Business
Table 65. Bharat Biotech Ltd. Mumps Vaccine Product and Services
Table 66. Bharat Biotech Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Bharat Biotech Ltd. Recent Developments/Updates
Table 68. Novavax, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Novavax, Inc. Major Business
Table 70. Novavax, Inc. Mumps Vaccine Product and Services
Table 71. Novavax, Inc. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Novavax, Inc. Recent Developments/Updates
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Mumps Vaccine Product and Services
Table 76. Novartis Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Novartis Recent Developments/Updates
Table 78. Sinovac Biotech, Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Sinovac Biotech, Ltd. Major Business
Table 80. Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
Table 81. Sinovac Biotech, Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Sinovac Biotech, Ltd. Recent Developments/Updates
Table 83. Incepta Vaccine Limited Basic Information, Manufacturing Base and Competitors
Table 84. Incepta Vaccine Limited Major Business
Table 85. Incepta Vaccine Limited Mumps Vaccine Product and Services
Table 86. Incepta Vaccine Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Incepta Vaccine Limited Recent Developments/Updates
Table 88. Valneva SE Basic Information, Manufacturing Base and Competitors
Table 89. Valneva SE Major Business
Table 90. Valneva SE Mumps Vaccine Product and Services
Table 91. Valneva SE Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Valneva SE Recent Developments/Updates
Table 93. VBI Vaccines Basic Information, Manufacturing Base and Competitors
Table 94. VBI Vaccines Major Business
Table 95. VBI Vaccines Mumps Vaccine Product and Services
Table 96. VBI Vaccines Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. VBI Vaccines Recent Developments/Updates
Table 98. PT Bio Farma Basic Information, Manufacturing Base and Competitors
Table 99. PT Bio Farma Major Business
Table 100. PT Bio Farma Mumps Vaccine Product and Services
Table 101. PT Bio Farma Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. PT Bio Farma Recent Developments/Updates
Table 103. Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 104. Sharp & Dohme Corp Major Business
Table 105. Sharp & Dohme Corp Mumps Vaccine Product and Services
Table 106. Sharp & Dohme Corp Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Sharp & Dohme Corp Recent Developments/Updates
Table 108. Bionity Basic Information, Manufacturing Base and Competitors
Table 109. Bionity Major Business
Table 110. Bionity Mumps Vaccine Product and Services
Table 111. Bionity Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Bionity Recent Developments/Updates
Table 113. Global Mumps Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 114. Global Mumps Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 115. Global Mumps Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 116. Market Position of Manufacturers in Mumps Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 117. Head Office and Mumps Vaccine Production Site of Key Manufacturer
Table 118. Mumps Vaccine Market: Company Product Type Footprint
Table 119. Mumps Vaccine Market: Company Product Application Footprint
Table 120. Mumps Vaccine New Market Entrants and Barriers to Market Entry
Table 121. Mumps Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Mumps Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 123. Global Mumps Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 124. Global Mumps Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 125. Global Mumps Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 126. Global Mumps Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 127. Global Mumps Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 128. Global Mumps Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 129. Global Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Global Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Global Mumps Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 132. Global Mumps Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 133. Global Mumps Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 134. Global Mumps Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 135. Global Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Global Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Global Mumps Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Global Mumps Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Global Mumps Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 140. Global Mumps Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 141. North America Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 142. North America Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 143. North America Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 144. North America Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 145. North America Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 146. North America Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 147. North America Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Europe Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Europe Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 152. Europe Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 153. Europe Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 154. Europe Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 155. Europe Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 156. Europe Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 157. Asia-Pacific Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 158. Asia-Pacific Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 159. Asia-Pacific Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 160. Asia-Pacific Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 161. Asia-Pacific Mumps Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 162. Asia-Pacific Mumps Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 163. Asia-Pacific Mumps Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 164. Asia-Pacific Mumps Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 165. South America Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 166. South America Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 167. South America Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 168. South America Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 169. South America Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 170. South America Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 171. South America Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 172. South America Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Middle East & Africa Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 174. Middle East & Africa Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 175. Middle East & Africa Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 176. Middle East & Africa Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 177. Middle East & Africa Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 178. Middle East & Africa Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 179. Middle East & Africa Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 180. Middle East & Africa Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 181. Mumps Vaccine Raw Material
Table 182. Key Manufacturers of Mumps Vaccine Raw Materials
Table 183. Mumps Vaccine Typical Distributors
Table 184. Mumps Vaccine Typical Customers
Table 1. Global Mumps Vaccine Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Mumps Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. MedImmune Basic Information, Manufacturing Base and Competitors
Table 4. MedImmune Major Business
Table 5. MedImmune Mumps Vaccine Product and Services
Table 6. MedImmune Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. MedImmune Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Mumps Vaccine Product and Services
Table 11. Johnson & Johnson Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co., Inc. Major Business
Table 15. Merck & Co., Inc. Mumps Vaccine Product and Services
Table 16. Merck & Co., Inc. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck & Co., Inc. Recent Developments/Updates
Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Mumps Vaccine Product and Services
Table 21. Sanofi Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sanofi Recent Developments/Updates
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Mumps Vaccine Product and Services
Table 26. Serum Institute of India Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Serum Institute of India Recent Developments/Updates
Table 28. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 29. Bavarian Nordic Major Business
Table 30. Bavarian Nordic Mumps Vaccine Product and Services
Table 31. Bavarian Nordic Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Bavarian Nordic Recent Developments/Updates
Table 33. Astellas Pharma India Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharma India Major Business
Table 35. Astellas Pharma India Mumps Vaccine Product and Services
Table 36. Astellas Pharma India Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Astellas Pharma India Recent Developments/Updates
Table 38. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 39. CSL Limited Major Business
Table 40. CSL Limited Mumps Vaccine Product and Services
Table 41. CSL Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. CSL Limited Recent Developments/Updates
Table 43. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 44. Emergent BioSolutions Major Business
Table 45. Emergent BioSolutions Mumps Vaccine Product and Services
Table 46. Emergent BioSolutions Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Emergent BioSolutions Recent Developments/Updates
Table 48. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 49. GlaxoSmithKline Major Business
Table 50. GlaxoSmithKline Mumps Vaccine Product and Services
Table 51. GlaxoSmithKline Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Panacea Biotec, Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Panacea Biotec, Ltd. Major Business
Table 55. Panacea Biotec, Ltd. Mumps Vaccine Product and Services
Table 56. Panacea Biotec, Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Panacea Biotec, Ltd. Recent Developments/Updates
Table 58. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 59. Biological E Limited Major Business
Table 60. Biological E Limited Mumps Vaccine Product and Services
Table 61. Biological E Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Biological E Limited Recent Developments/Updates
Table 63. Bharat Biotech Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Bharat Biotech Ltd. Major Business
Table 65. Bharat Biotech Ltd. Mumps Vaccine Product and Services
Table 66. Bharat Biotech Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Bharat Biotech Ltd. Recent Developments/Updates
Table 68. Novavax, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Novavax, Inc. Major Business
Table 70. Novavax, Inc. Mumps Vaccine Product and Services
Table 71. Novavax, Inc. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Novavax, Inc. Recent Developments/Updates
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Mumps Vaccine Product and Services
Table 76. Novartis Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Novartis Recent Developments/Updates
Table 78. Sinovac Biotech, Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Sinovac Biotech, Ltd. Major Business
Table 80. Sinovac Biotech, Ltd. Mumps Vaccine Product and Services
Table 81. Sinovac Biotech, Ltd. Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Sinovac Biotech, Ltd. Recent Developments/Updates
Table 83. Incepta Vaccine Limited Basic Information, Manufacturing Base and Competitors
Table 84. Incepta Vaccine Limited Major Business
Table 85. Incepta Vaccine Limited Mumps Vaccine Product and Services
Table 86. Incepta Vaccine Limited Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Incepta Vaccine Limited Recent Developments/Updates
Table 88. Valneva SE Basic Information, Manufacturing Base and Competitors
Table 89. Valneva SE Major Business
Table 90. Valneva SE Mumps Vaccine Product and Services
Table 91. Valneva SE Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Valneva SE Recent Developments/Updates
Table 93. VBI Vaccines Basic Information, Manufacturing Base and Competitors
Table 94. VBI Vaccines Major Business
Table 95. VBI Vaccines Mumps Vaccine Product and Services
Table 96. VBI Vaccines Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. VBI Vaccines Recent Developments/Updates
Table 98. PT Bio Farma Basic Information, Manufacturing Base and Competitors
Table 99. PT Bio Farma Major Business
Table 100. PT Bio Farma Mumps Vaccine Product and Services
Table 101. PT Bio Farma Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. PT Bio Farma Recent Developments/Updates
Table 103. Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
Table 104. Sharp & Dohme Corp Major Business
Table 105. Sharp & Dohme Corp Mumps Vaccine Product and Services
Table 106. Sharp & Dohme Corp Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Sharp & Dohme Corp Recent Developments/Updates
Table 108. Bionity Basic Information, Manufacturing Base and Competitors
Table 109. Bionity Major Business
Table 110. Bionity Mumps Vaccine Product and Services
Table 111. Bionity Mumps Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Bionity Recent Developments/Updates
Table 113. Global Mumps Vaccine Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 114. Global Mumps Vaccine Revenue by Manufacturer (2020-2025) & (USD Million)
Table 115. Global Mumps Vaccine Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 116. Market Position of Manufacturers in Mumps Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 117. Head Office and Mumps Vaccine Production Site of Key Manufacturer
Table 118. Mumps Vaccine Market: Company Product Type Footprint
Table 119. Mumps Vaccine Market: Company Product Application Footprint
Table 120. Mumps Vaccine New Market Entrants and Barriers to Market Entry
Table 121. Mumps Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Mumps Vaccine Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 123. Global Mumps Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 124. Global Mumps Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 125. Global Mumps Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 126. Global Mumps Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 127. Global Mumps Vaccine Average Price by Region (2020-2025) & (US$/Unit)
Table 128. Global Mumps Vaccine Average Price by Region (2026-2031) & (US$/Unit)
Table 129. Global Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Global Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Global Mumps Vaccine Consumption Value by Type (2020-2025) & (USD Million)
Table 132. Global Mumps Vaccine Consumption Value by Type (2026-2031) & (USD Million)
Table 133. Global Mumps Vaccine Average Price by Type (2020-2025) & (US$/Unit)
Table 134. Global Mumps Vaccine Average Price by Type (2026-2031) & (US$/Unit)
Table 135. Global Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Global Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Global Mumps Vaccine Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Global Mumps Vaccine Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Global Mumps Vaccine Average Price by Application (2020-2025) & (US$/Unit)
Table 140. Global Mumps Vaccine Average Price by Application (2026-2031) & (US$/Unit)
Table 141. North America Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 142. North America Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 143. North America Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 144. North America Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 145. North America Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 146. North America Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 147. North America Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Europe Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Europe Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 152. Europe Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 153. Europe Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 154. Europe Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 155. Europe Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 156. Europe Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 157. Asia-Pacific Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 158. Asia-Pacific Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 159. Asia-Pacific Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 160. Asia-Pacific Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 161. Asia-Pacific Mumps Vaccine Sales Quantity by Region (2020-2025) & (K Units)
Table 162. Asia-Pacific Mumps Vaccine Sales Quantity by Region (2026-2031) & (K Units)
Table 163. Asia-Pacific Mumps Vaccine Consumption Value by Region (2020-2025) & (USD Million)
Table 164. Asia-Pacific Mumps Vaccine Consumption Value by Region (2026-2031) & (USD Million)
Table 165. South America Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 166. South America Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 167. South America Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 168. South America Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 169. South America Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 170. South America Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 171. South America Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 172. South America Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Middle East & Africa Mumps Vaccine Sales Quantity by Type (2020-2025) & (K Units)
Table 174. Middle East & Africa Mumps Vaccine Sales Quantity by Type (2026-2031) & (K Units)
Table 175. Middle East & Africa Mumps Vaccine Sales Quantity by Application (2020-2025) & (K Units)
Table 176. Middle East & Africa Mumps Vaccine Sales Quantity by Application (2026-2031) & (K Units)
Table 177. Middle East & Africa Mumps Vaccine Sales Quantity by Country (2020-2025) & (K Units)
Table 178. Middle East & Africa Mumps Vaccine Sales Quantity by Country (2026-2031) & (K Units)
Table 179. Middle East & Africa Mumps Vaccine Consumption Value by Country (2020-2025) & (USD Million)
Table 180. Middle East & Africa Mumps Vaccine Consumption Value by Country (2026-2031) & (USD Million)
Table 181. Mumps Vaccine Raw Material
Table 182. Key Manufacturers of Mumps Vaccine Raw Materials
Table 183. Mumps Vaccine Typical Distributors
Table 184. Mumps Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Mumps Vaccine Picture
Figure 2. Global Mumps Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Mumps Vaccine Revenue Market Share by Type in 2024
Figure 4. Child Examples
Figure 5. Adult Examples
Figure 6. Global Mumps Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Mumps Vaccine Revenue Market Share by Application in 2024
Figure 8. Hospitals Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Global Mumps Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Mumps Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Mumps Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 13. Global Mumps Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global Mumps Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Mumps Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Mumps Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Mumps Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Mumps Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Mumps Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Mumps Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Mumps Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Mumps Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Mumps Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global Mumps Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Mumps Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Mumps Vaccine Market Drivers
Figure 73. Mumps Vaccine Market Restraints
Figure 74. Mumps Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2024
Figure 77. Manufacturing Process Analysis of Mumps Vaccine
Figure 78. Mumps Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Mumps Vaccine Picture
Figure 2. Global Mumps Vaccine Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Mumps Vaccine Revenue Market Share by Type in 2024
Figure 4. Child Examples
Figure 5. Adult Examples
Figure 6. Global Mumps Vaccine Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Mumps Vaccine Revenue Market Share by Application in 2024
Figure 8. Hospitals Pharmacies Examples
Figure 9. Retail Pharmacies Examples
Figure 10. Global Mumps Vaccine Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Mumps Vaccine Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Mumps Vaccine Sales Quantity (2020-2031) & (K Units)
Figure 13. Global Mumps Vaccine Price (2020-2031) & (US$/Unit)
Figure 14. Global Mumps Vaccine Sales Quantity Market Share by Manufacturer in 2024
Figure 15. Global Mumps Vaccine Revenue Market Share by Manufacturer in 2024
Figure 16. Producer Shipments of Mumps Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 17. Top 3 Mumps Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 18. Top 6 Mumps Vaccine Manufacturer (Revenue) Market Share in 2024
Figure 19. Global Mumps Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 20. Global Mumps Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 21. North America Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 22. Europe Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 23. Asia-Pacific Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 24. South America Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 25. Middle East & Africa Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 26. Global Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 27. Global Mumps Vaccine Consumption Value Market Share by Type (2020-2031)
Figure 28. Global Mumps Vaccine Average Price by Type (2020-2031) & (US$/Unit)
Figure 29. Global Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 30. Global Mumps Vaccine Revenue Market Share by Application (2020-2031)
Figure 31. Global Mumps Vaccine Average Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 33. North America Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 34. North America Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 35. North America Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 40. Europe Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 41. Europe Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 42. Europe Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 44. France Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Mumps Vaccine Sales Quantity Market Share by Region (2020-2031)
Figure 51. Asia-Pacific Mumps Vaccine Consumption Value Market Share by Region (2020-2031)
Figure 52. China Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 53. Japan Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 54. South Korea Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 55. India Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 56. Southeast Asia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 57. Australia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 58. South America Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 59. South America Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 60. South America Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 61. South America Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 62. Brazil Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 63. Argentina Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 64. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Type (2020-2031)
Figure 65. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Application (2020-2031)
Figure 66. Middle East & Africa Mumps Vaccine Sales Quantity Market Share by Country (2020-2031)
Figure 67. Middle East & Africa Mumps Vaccine Consumption Value Market Share by Country (2020-2031)
Figure 68. Turkey Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 69. Egypt Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 70. Saudi Arabia Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 71. South Africa Mumps Vaccine Consumption Value (2020-2031) & (USD Million)
Figure 72. Mumps Vaccine Market Drivers
Figure 73. Mumps Vaccine Market Restraints
Figure 74. Mumps Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Mumps Vaccine in 2024
Figure 77. Manufacturing Process Analysis of Mumps Vaccine
Figure 78. Mumps Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
